title: Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent.
authors.affiliation: Department of Joint Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan. takedani@ims.u-tokyo.ac.jp.
authors.forename: H
authors.initials: H
authors.lastname: Takedani
authors.affiliation: Department of Joint Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Hirose
authors.affiliation: Department of Joint Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
authors.forename: F
authors.initials: F
authors.lastname: Minamoto
authors.affiliation: Department of Joint Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Kubota
authors.affiliation: Department of Joint Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Kinkawa
authors.affiliation: Department of Joint Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Noguchi
mesh_terms: D000293:Adolescent; D057134:Antibodies, Neutralizing / Q000097:blood*; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D003029:Coagulants / Q000627:therapeutic use*; D015942:Factor VIIa / Q000378:metabolism / Q000627:therapeutic use; D005170:Factor X / Q000378:metabolism / Q000627:therapeutic use; D002836:Hemophilia B / Q000188:drug therapy* / Q000473:pathology; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D008297:Male; D019637:Orthopedic Procedures; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D057134:Antibodies, Neutralizing; D001779:Blood Coagulation Factors; D003029:Coagulants; D011994:Recombinant Proteins; D005170:Factor X; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa